Colgate Palmolive is looking at ways to reduce the impact of possible tariffs on its toothpastes, which the company ...

Colgate-Palmolive forecasts annual sales below expectations due to weak demand in North America and Latin America. The ...

Toothpaste maker Colgate-Palmolive expects annual sales below Wall Street expectations after missing quarterly sales ...

Q4 2024 Management View CEO Noel Wallace highlighted net sales of $20 billion in 2024, achieving this milestone one year ...

The most important thing, according to Michael Glogauer, dentist-in-chief at University Health Network, is to find a ...

Colgate-Palmolive reported stable earnings for Q4 2024, beating EPS estimates but just missing revenue expectations.

Strong earnings, soaring organic sales, and record-breaking margins--Colgate is winning, but currency headwinds loom.

The company's net sales in Latin America, a major revenue contributing region, fell 7.2 per cent and dropped 1 per cent in ...

Buying Colgate-Palmolive Company shares after their 20% drop may not be a good idea for dividend or total return investors.

Ltd has reported a steady yet somewhat subdued financial performance for the third quarter and nine months ending 31 December 2024. In a world where Pepsodent, Sensodyne, and a slew of herbal ...

Colgate Palmolive (India) reported a third-quarter profit that came in below market estimates on Tuesday, hurt by dwindling demand from urban consumers and higher expenses.